Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 479

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 479
---
000 units, at $10.00 per unit (“ Units”), generating gross proceeds of $60,000,000 before underwriting discounts and expenses. Simultaneously with the closing of BLAC’s IPO, the Sponsor purchased an aggregate of 430,000 units at a price of $10.00 per unit, for an aggregate purchase price of $4,300,000 (“ Private Placement Units”). In connection with the IPO, the underwriters were granted a 45 -dayoption from the date of IPO prospectus (the “ Over-Allotment Option”) to purchase up to 900,000 additional Units to cover over -allotments(the “ Over-Allotment Units”), if any. On February 21, 2023, the underwriters purchased 900,000 Over -AllotmentUnits fully exercising the Over -AllotmentOption. The Over -AllotmentUnits were sold at an offering price of $10.00 per Over -AllotmentUnit, generating additional gross proceeds of $9,000,000 to BLAC. Effecting a Business Combination On November 16, 2023, BLAC entered into the Business Combination Agreement, which was amended and restated on May 23, 2024, and was further amended on December 20, 2024. As a result of the transaction and if approved at the BLAC Stockholders’ Meeting, BLAC will change its name to “OSR Holdings, Inc.” while OSR Holdings will become a majority owned subsidiary of the BLAC. In the event that the Business Combination is not consummated by the Termination Date, BLAC’s corporate existence will cease and BLAC will distribute the proceeds held in the Trust Account to its Public Stockholders. Redemption Rights for Holders of Public Shares BLAC is providing its Public Stockholders with redemption rights upon consummation of the Business Combination. Public Stockholders electing to exercise their redemption rights will be entitled to receive the cash amount specified in the proxy statement/prospectus, provided that such stockholders follow the specific procedures for redemption set forth in this proxy statement/prospectus relating to the shareholder vote on the Business Combination. BLAC’s Public Stockholders are not required to vote against the Business Combination in order to exercise their redemption rights. If the Business Combination is not completed, then Public Stockholders electing to exercise their redemption rights will not be entitled to receive such payments. The Sponsor, BLAC’s officers and directors and their respective affiliates agreed, at the